Oral Nanatinostat (Nstat) and Valganciclovir (VGCV) in Patients with Recurrent Epstein-Barr Virus (EBV)-Positive Lymphomas: Initial Phase 2 Results

被引：2
|
作者：
Porcu, Pierluigi
Haverkos, Bradley
Alpdogan, Onder
Baiocchi, Robert
Brammer, Jonathan E.
Feldman, Tatyana A.
Capra, Marcelo
Brem, Elizabeth A.
Scheinberg, Phillip
Pereira, Juliana
Shune, Leyla
Katkov, Afton
Mcrae, Robert
Rojkjaer, Lisa
Royston, Ivor
Faller, Douglas V.
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-140843
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Epstein-Barr virus (EBV)-positive pyothorax-associated lymphoma (PAL): chromosomal integration of EBV in a novel CD2-positive PAL B-cell line
    Daibata, M
    Taguchi, T
    Nemoto, Y
    Saito, T
    Machida, H
    Imai, S
    Miyoshi, I
    Taguchi, H
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 117 (03) : 546 - 557
  • [42] Long-Term Outcomes in Epstein-Barr Virus (EBV)-Positive Patients Receiving Belatacept (Bela) or Cyclosporine (CsA) in BENEFIT-EXT.
    Florman, S.
    Pestana, J. Medina
    Rial, M. del C.
    Rostaing, L.
    Kuypers, D.
    Matas, A.
    Wekerle, T.
    Grinyo, J.
    Meier-Kriesche, U.
    Polinsky, M.
    Zhao, H.
    Durrbach, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 743 - 743
  • [43] Age-related Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients
    Asano, Naoko
    Yamamoto, Kazuhito
    Tamaru, Jun-Ichi
    Oyama, Takashi
    Ishida, Fumihiro
    Ohshima, Koichi
    Yoshino, Tadashi
    Nakamura, Naoya
    Mori, Shigeo
    Yoshie, Osamu
    Shimoyama, Yoshie
    Morishima, Yasuo
    Kinoshita, Tomohiro
    Nakamura, Shigeo
    BLOOD, 2009, 113 (12) : 2629 - 2636
  • [44] Ex vivo production of LMP2-specific cytotoxic T-lymphocytes as a treatment for Epstein-Barr virus-positive lymphomas
    不详
    CLINICAL LYMPHOMA, 2004, 5 (01): : 10 - 11
  • [45] Latent Expression of the Epstein-Barr Virus (EBV)-Encoded Major Histocompatibility Complex Class I TAP Inhibitor, BNLF2a, in EBV-Positive Gastric Carcinomas
    Strong, Michael J.
    Laskow, Thomas
    Nakhoul, Hani
    Blanchard, Eugene
    Liu, Yaozhong
    Wang, Xia
    Baddoo, Melody
    Lin, Zhen
    Yin, Qinyan
    Flemington, Erik K.
    JOURNAL OF VIROLOGY, 2015, 89 (19) : 10110 - 10114
  • [46] Epstein-Barr virus and gastric carcinoma in Western patients: comparison of pathological parameters and p53 expression in EBV-positive and negative tumours
    Chapel, F
    Fabiani, B
    Davi, F
    Raphael, M
    Tepper, M
    Champault, G
    Guettier, C
    HISTOPATHOLOGY, 2000, 36 (03) : 252 - 261
  • [47] LONG-TERM OUTCOMES IN EPSTEIN-BARR VIRUS POSITIVE (EBV plus ) PATIENTS RECEIVING BELATACEPT (BELA) OR CYCLOSPORINE (CSA) IN BENEFIT-EXT
    Florman, S.
    Medina Pestana, J.
    Rial, M. Del C.
    Rostaing, L.
    Kuypers, D.
    Matas, A.
    Wekerle, T.
    Grinyo, J.
    Meier-Kriesche, U.
    Polinsky, M.
    Zhao, H.
    Durrbach, A.
    TRANSPLANT INTERNATIONAL, 2017, 30 : 7 - 7
  • [48] Preferential localization of the Epstein-Barr virus (EBV) oncoprotein LMP-1 to nuclei in human T cells: Implications for its role in the development of EBV genome-positive T-Cell lymphomas
    Xu, JW
    Ahmad, A
    Menezes, J
    JOURNAL OF VIROLOGY, 2002, 76 (08) : 4080 - 4086
  • [49] DISCORDANCE OF EPSTEIN-BARR VIRUS (EBV) SPECIFIC HUMORAL AND CELLULAR IMMUNITY IN PATIENTS WITH MALIGNANT-LYMPHOMAS - ELEVATED ANTIBODY TITERS AND LOWERED INVITRO LYMPHOCYTE-REACTIVITY
    TENNAPEL, CHH
    THE, TH
    VANEGTENBIJKER, J
    GAST, GCD
    HALIE, MR
    LANGENHUYSEN, MMAC
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1978, 34 (03): : 338 - 346
  • [50] Phase I Clinical Trial of 4-1BB-based Adoptive T-Cell Therapy for Epstein-Barr Virus (EBV)-positive Tumors
    Eom, Hyeon-Seok
    Choi, Beom K.
    Lee, Youngjoo
    Lee, Hyewon
    Yun, Tak
    Kim, Young H.
    Lee, Je-Jung
    Kwon, Byoung S.
    JOURNAL OF IMMUNOTHERAPY, 2016, 39 (03) : 140 - 148
12345